tiprankstipranks
CV Sciences Inc (CVSI)
OTHER OTC:CVSI
Holding CVSI?
Track your performance easily

CV Sciences (CVSI) Stock Price & Analysis

473 Followers

CVSI Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.02%<0.01%99.98%
0.02%
Insiders
<0.01% Other Institutional Investors
99.98% Public Companies and
Individual Investors

CVSI FAQ

What was CV Sciences Inc’s price range in the past 12 months?
CV Sciences Inc lowest stock price was $0.03 and its highest was $0.10 in the past 12 months.
    What is CV Sciences Inc’s market cap?
    Currently, no data Available
    When is CV Sciences Inc’s upcoming earnings report date?
    CV Sciences Inc’s upcoming earnings report date is Mar 27, 2025 which is in 93 days.
      How were CV Sciences Inc’s earnings last quarter?
      CV Sciences Inc released its earnings results on Nov 14, 2024. The company reported -$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.002.
        Is CV Sciences Inc overvalued?
        According to Wall Street analysts CV Sciences Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CV Sciences Inc pay dividends?
          CV Sciences Inc does not currently pay dividends.
          What is CV Sciences Inc’s EPS estimate?
          CV Sciences Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does CV Sciences Inc have?
          CV Sciences Inc has 184,263,660 shares outstanding.
            What happened to CV Sciences Inc’s price movement after its last earnings report?
            CV Sciences Inc reported an EPS of -$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of CV Sciences Inc?
              Currently, no hedge funds are holding shares in CVSI
              ---

              Company Description

              CV Sciences Inc

              CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, California.
              ---

              CVSI Earnings Call

              Q3 2024
              0:00 / 0:00
              Earnings Call Sentiment|Neutral
              The earnings call presented a mix of steady performance in revenue and gross margins, successful product launches, and strategic acquisitions. However, the company faces challenges such as a decline in unit sales, revenue impact from regulatory changes in California, and a slight decrease in cash reserves. The sentiment remains cautiously optimistic due to the company's market leadership and strategic initiatives.Read More>
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              General Cannabis
              Medical Marijuana
              Cannabis Sativa
              CNBX Pharmaceuticals
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis